2024年9月13日-17日，欧洲肿瘤内科学会（ESMO）年会将于在西班牙巴塞罗那召开，作为肿瘤内科最高规模的国际盛会，涉及肺癌、乳腺癌、消化道肿瘤、泌尿生殖系统肿瘤等领域的多项研究届时皆将披露最新进展。

In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...

All medicines have risks and benefits. Your doctor has weighed the risks of you using oxaliplatin against the benefits they expect it will have for you. If you have any concerns about taking this ...

causing drug withdrawal in oxaliplatin-treated patients, although less frequently than in cisplatin or carboplatin treatment 18. For these reasons I believe that all the physicians and researchers ...

The UK’s MHRA has approved Takeda’s Fruzaqla (fruquintinib) for metastatic colorectal cancer (CRC) in adults who have not ...

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.

CRC is an abnormal growth of cells that begins in a part of the large intestine called the colon. When the cancer is ...

For example, the CAIRO2 trial showed that addition of cetuximab to capecitabine (Xeloda; Roche), oxaliplatin and bevacizumab resulted in significantly shorter progression-free survival and ...

Afabicin is under clinical development by Debiopharm International and currently in Phase II for Osteomyelitis.

Medscape Oncology, March 08, 2024 Oxaliplatin in Older Adults With Resected Colorectal Cancer? Dr David Kerr discusses the use of adjuvant chemotherapy with oxaliplatin to high-risk patients with ...

Adding nivolumab to adjuvant chemotherapy does not improve outcomes in patients with stage III gastric or gastro-esophageal junction cancer, according to results from the phase 3 ATTRACTION-5 trial.

This white-hot metal not only makes beautiful jewelry, it's coveted for industrial, medical and military purposes too.